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Abstract
Background: The main role of the chromosomal passenger complex is to ensure that Aurora B
kinase is properly localized and activated before and during mitosis. Borealin, a member of the
chromosomal passenger complex, shows increased expression during G2/M phases and is involved
in targeting the complex to the centromere and the spindle midzone, where it ensures proper
chromosome segregation and cytokinesis. Borealin has a consensus CDK1 phosphorylation site,
threonine 106 and can be phosphorylated by Aurora B Kinase at serine 165 in vitro.
Results:  Here, we show that Borealin is phosphorylated during mitosis in human cells.
Dephosphorylation of Borealin occurs as cells exit mitosis. The phosphorylated form of Borealin
is found in an INCENP-containing complex in mitosis. INCENP-containing complexes from cells in
S phase are enriched in the phosphorylated form suggesting that phosphorylation may encourage
entry of Borealin into the chromosomal passenger complex. Although Aurora B Kinase is found in
complexes that contain Borealin, it is not required for the mitotic phosphorylation of Borealin.
Mutation of T106 or S165 of Borealin to alanine does not alter the electrophoretic mobility shift
of Borealin. Experiments with cyclohexamide and the phosphatase inhibitor sodium fluoride
suggest that Borealin is phosphorylated by a protein kinase that can be active in interphase and
mitosis and that the phosphorylation may be regulated by a short-lived phosphatase that is active
in interphase but not mitosis.
Conclusion:  Borealin is phosphorylated during mitosis. Neither residue S165, T106 nor
phosphorylation of Borealin by Aurora B Kinase is required to generate the mitotic, shifted form
of Borealin. Suppression of phosphorylation during interphase is ensured by a labile protein,
possibly a cell cycle regulated phosphatase.
Background
The chromosomal passenger complex (CPC) consisting of
Aurora B kinase, INCENP (INner CENtromere Protein),
Survivin and Borealin/Dasra B plays important roles dur-
ing mitosis and cytokinesis [1]. One of the main aims of
the CPC proteins is to ensure that Aurora B is accessible to
phosphorylate its various substrates like histone H3,
CENP-A, MKLP1, MCAK, INCENP, Survivin, MgcRacGAP,
Vimentin, Desmin and myosin-II [2-14] at the right time.
Thus, the CPC proteins regulate multiple mitotic events
like chromosome segregation, operation of the spindle
assembly checkpoint and cytokinesis [1]. How phosphor-
ylation by Aurora B affects the functions of its various sub-
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strates and hence influences cell division is not
completely understood.
The CPC proteins concentrate at the inner-centromere
during metaphase, migrate to the spindle midzone during
anaphase and finally to midbody during cytokinesis [1].
The exact mechanism of this characteristic localization of
the CPC is currently unknown, however clues are emerg-
ing. Borealin and Survivin can self-associate in vitro and in
vivo and can also interact with each other [15-20]. Borea-
lin can bind to DNA in vitro [20]. Also, the BIR-domain of
Survivin has been proposed to interact with the centro-
meres [21]. Furthermore, a complex of Borealin, Survivin
and the N-terminus of INCENP (1–58) is capable of tar-
geting to the centromere in vivo [20]. Borealin and Sur-
vivin may act as a scaffold to bring INCENP and Aurora B
Kinase to the centromere. INCENP can bind to tubulin
directly thereby targeting the CPC to the spindle midzone
[22-24].
Several members of the CPC are regulated by post-transla-
tional modification. For example, INCENP is phosphor-
ylated by Aurora B and CDK1, both of which enhance the
ability of INCENP to activate Aurora B [25,26]. Also, the
phosphorylation of INCENP by CDK1 allows it to interact
with Plk1 and recruit it to the centromere [26]. There is
also evidence that Survivin is regulated by phosphoryla-
tion [10]. Borealin co-localizes with Aurora B Kinase and
can be phosphorylated at serine 165 by Aurora B Kinase in
vitro [18]. Here, we show that Borealin is phosphorylated
in vivo during mitosis as indicated by an electrophoretic
mobility shift. Aurora B is not required for this particular
modification. Mutation of S165, potential Aurora B
Kinase phosphorylation site, to alanine did not alter the
mitotic phosphorylation of Borealin or its localization to
the centromere, spindle midzone or midbody indicating
that other sites are targets of modification in vivo.
Results
Two electrophoretic forms of Borealin in human cells
During our analysis of the expression of Flag-tagged Bore-
alin protein, we periodically observed two bands. There-
fore, we transiently transfected Hela cells with WT Flag-
Borealin and separated the extracts by more extensive elec-
trophoresis using a modified acrylamide/bisacrylamide
ratio (see Methods). Under these conditions, we found
that Borealin could be resolved into a doublet (Fig. 1A,
compare UT to WT). The presence of two migrating forms
suggests that Borealin may be post-translationally modi-
fied in cells. Furthermore, we observed that cells blocked
in mitosis with nocodazole contained mostly the slowly
migrating form whereas asynchronously growing cells
contained the faster form (Fig. 1B). Nocodazole arrests
cells in mitosis by preventing microtubule polymerization
which activates the spindle checkpoint. This raised two
possibilities, either that Borealin was modified as cells
naturally entered mitosis, or that it was modified as a con-
sequence of triggering the spindle checkpoint.
Mitotic WT-8 cells collected by mitotic shake-off in the
absence of nocodazole contained mostly the slowly
migrating form of Borealin, similarly to nocodazole
blocked cells (Fig. 1B). This suggests that the modification
of Borealin that we have identified occurs as cells naturally
enter mitosis, and is not a consequence of activation of
the spindle checkpoint. In addition, the mitosis-specific
mobility shift of wild-type Borealin was observed in two
independent stable clones that express different levels of
the ectopic protein (Fig. 1C and 1D). This suggests that
phosphorylation is not clone specific and can be seen
when lower levels of the protein are expressed.
Borealin is found in a complex with Aurora B, a serine/
threonine kinase that is active during mitosis and not
interphase [18,19]. Also, Aurora B can phosphorylate ser-
ine 165 of Borealin in vitro [18]. One possibility was that
the mobility shift we observed during mitosis was due to
phosphorylation of the protein by Aurora B Kinase. There-
fore, we mutated S164 and S165 to alanine (hereafter
named S165A) and transiently transfected the mutant
into Hela cells. Borealin migrated as a doublet even when
S165A was mutated to alanine (Fig. 1A) suggesting that
phosphorylation of S165 is not required to generate the
shifted form of Borealin. Also, the S165A form of Borealin
localized to the centromeres during metaphase, to the
spindle midzone during anaphase and to the midbody
during telophase similarly to wild-type Borealin (Fig. 2).
By database searching, we found that T106 of Borealin
conforms to the consensus for CDK1 phosphorylation.
Similarly to S164/5, mutation of T106 to alanine did not
reduce the mobility shift of the protein in mitosis and had
no effect on its subcellular localization (our unpublished
data).
Analysis of endogenous Borealin
To analyze endogenous Borealin, we raised an antiserum
to the human protein. Asynchronously growing and
mitotic Hela cells were assessed by Western blotting to
determine if endogenous Borealin showed a mobility
shift. Western blot analysis of untransfected, Hela cells
using the antibody to Borealin revealed the presence of
two electrophoretic forms of Borealin (Fig. 3). Also,
mitotic cells showed an increase in the slowly migrating
form of Borealin similar to the Flag-tagged Borealin. West-
ern blot analysis of WT-8 cells containing the Flag-tagged
Borealin using our antibody to Borealin revealed four
bands during mitosis, with the upper two bands being rec-
ognized by the antibody to the Flag-tag (Fig. 3). The
slower migration of the Flag-tagged Borealin is apparently
due to the extra 8 amino acids comprising the tag. Also,BMC Cell Biology 2007, 8:5 http://www.biomedcentral.com/1471-2121/8/5
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Mobility shift of exogenous Borealin Figure 1
Mobility shift of exogenous Borealin. Mobility shift and protein levels of exogenous Borealin in (A), (B), (C) and (D) were 
determined by Western blotting using an antibody to the Flag-tag. Transfers were stripped and reprobed for β-actin as a load-
ing control. UT: untransfected. The multiple blocks in (A) are bands from the same gel. (A) Two electrophoretic forms of 
Borealin. Asynchronously growing Hela cells were transiently transfected with either wild type or S165A phosphomutant of 
Borealin. Transfected cells were either left untreated or treated with nocodazole for 14 hours to block cells in mitosis. Cell 
lysates were separated using 15% SDS-polyacrylamide gel. (B) Mobility shift of exogenous Borealin. Mitotic WT-8 cells were 
collected either by mitotic shake-off or by using nocodazole. Cell lysates were separated on a 12.6% SDS-polyacrylamide gel 
and analyzed by Western blotting. Lysates were less concentrated than those used in "A" and in asynchronous cells (No NOC) 
only the more abundant faster migrating form is visible. (C) Expression level of ectopic Borealin in different clones. Clones of 
Hela cells stably expressing different levels of wild-type Flag-Borealin were analyzed by Western blotting using 12.5% SDS-poly-
acrylamide gel. (D) Mobility shift of Borealin in WT-1. WT-1 cells stably expressing a lower level of wild-type Flag-Borealin 
than WT-8 were either left to grow asynchronously (No NOC) or blocked in mitosis using nocodazole (NOC). Cell lysates 
were separated on a 12.6% SDS-polyacrylamide gel. (E) Expression of GFP in Hela cells. Hela cells were transiently transfected 
with CMV-gfp and left to grow either asynchronously or treated with nocodazole. Cell lysates were separated by 12.5% SDS-
polyacrylamide gel and subjected to Western blotting with anti-GFP antibody.
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Localization of ectopic wild type or S165A mutated version of Borealin Figure 2
Localization of ectopic wild type or S165A mutated version of Borealin. Hela cells were transiently transfected with wild type 
or S165A phosphomutant of Borealin. Localization of ectopic Borealin (BOR-red), α-tubulin (α-TUB-green) and DNA (DNA-
blue) in cells was analyzed using fluorescence microscopy. M denotes Metaphase, A denotes Anaphase and T denotes Telo-
phase.
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the Flag-tagged Borealin in WT-8 cells appears to be less
abundant than the endogenous protein. These results
indicate that our observations with the Flag-tagged pro-
tein are not due to overexpression.
Phosphorylation of Borealin during mitosis
To determine if the electrophoretic mobility shift of Bore-
alin is due to phosphorylation, mitotic extracts of Hela
cells transiently transfected with Flag- Borealin were
treated with phosphatase for one and four hours and as a
control, with phosphatase and phosphatase inhibitor. The
disappearance of the slower migrating form of Borealin
upon phosphatase treatment suggests that the slower
mobility is due to phosphorylation (Fig. 4A). The fact that
adding phosphatase inhibitor blocked the ability of the
phosphatase to convert the slower migrating band to the
faster migrating band further confirms that the protein is
phosphorylated, and that the conversion between forms is
not due to contamination of the phosphatase with other
enzymatic activities (Fig. 4A). These results demonstrate
that Borealin is phosphorylated in vivo during mitosis. In
the experiment shown, a clone stably expressing a phos-
phomutant of Borealin T106A was analyzed, however
similar results were obtained with wild-type Flag-Borealin
and endogenous Borealin (Fig. 4A).
The majority of Borealin is dephosphorylated in asyn-
chronously growing cells, and phosphorylated during
mitosis. To determine if Borealin is dephosphorylated as
cells exit mitosis we synchronized WT-8 cells in mitosis by
exposure to nocodazole. Borealin was analyzed by West-
ern blotting at various time points after release from the
nocodazole block. Cells were harvested up to 8 hours post
release to determine the mobility shift of Borealin and the
level of Cyclin B1 as a control for mitotic exit. At 1-hour
post release, Borealin is mostly in the slower migrating
phosphorylated form (Fig. 4B). At 1-hour post release we
consistently observe a ~30% increase in the total level of
Borealin protein compared to cells blocked with nocoda-
zole (Fig. 4B). Dephosphorylation of Borealin is just visi-
ble at 2 hours and by 8 hours, cells show an abundant,
faster migrating, dephosphorylated form of Borealin. Cyc-
lin B1 levels decreased by 8 hours indicating that the cells
have exited mitosis (Fig. 4B). Thus, the dephosphoryla-
tion of Borealin correlates with Cyclin B1 degradation.
Levels of ectopic Borealin in mitosis
We observed a higher level of Flag-Borealin protein when
cells were arrested in mitosis (Fig. 1A). In addition, the
mutant of Borealin in which S165 was changed to alanine
also accumulated to higher levels when cells were blocked
Mobility shift of endogenous Borealin Figure 3
Mobility shift of endogenous Borealin. Cell lysates of asynchronously growing and mitotic Hela and WT-8 cells were separated 
using 12.6% SDS-polyacrylamide gel and assessed by Western blotting (WB) using antibodies to endogenous (end) Borealin or 
the Flag-tag. Transfers were stripped and reprobed for β-actin as a loading control.
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Phosphorylation of Borealin in mitosis Figure 4
Phosphorylation of Borealin in mitosis. Hela cells were transfected with Flag-Borealin that was analyzed by Western blotting 
with an antibody to the Flag-tag and endogenous Borealin. (A) Mitotic phosphorylation of Borealin. Hela cells transiently trans-
fected with the T106A mutant of Borealin were either allowed to grow asynchronously or blocked in mitosis using nocoda-
zole. Lysates from transfected, mitotic cells were treated with phosphatase for 1 hrs (PP1) and 4 hrs (PP4) in vitro and also with 
phosphatase inhibitor (PP+Inh). Cell lysates were run on a 15% or 12.6% SDS-polyacrylamide gel. * : Nocodazole treated cells, 
only the upper, shifted form of Flag-tagged and endogenous Borealin is observed. (B) WT-8 cells were blocked in mitosis using 
nocodazole and then released into fresh medium. Cells were harvested at the indicated time points and cell lysates were sepa-
rated by a long run on a 12.6% SDS-polyacrylamide gel. Membranes were stripped and reprobed for Cyclin B1 as a marker for 
progression through the cell cycle and for β-actin as a loading control.
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in mitosis compared to when they were growing asyn-
chronously (Fig. 1A). The Flag-Borealin used is under the
transcriptional control of the cytomegalovirus (CMV)
promoter. CMV has been reported to be active throughout
the cell cycle [27]. To confirm this in our cells we tran-
siently transfected them with green fluorescent protein
(GFP) under the control of the CMV promoter. Similar
levels of GFP protein were observed in interphase and
mitotic cells suggesting that the overexpression of Borea-
lin is not due to changes in transcription (Fig. 1E).
Mitotic phosphorylation of Borealin is not dependent on 
Aurora B Kinase
During mitosis, Borealin co-localizes with Aurora B, a
mitotic kinase that can phosphorylate S165 of Borealin in
vitro [18]. Phosphorylation of S165 is not required to gen-
erate the mitotic mobility shift of Borealin. However, it
was possible that Aurora B phosphorylates a different site
to induce the mobility shift. Therefore, we tested the effect
of ZM447439, an effective inhibitor of Aurora B kinase
activity on the mitotic phosphorylation of Borealin
[28,29]. Hela, A549 and HME cells treated with 2 μM
ZM447439 enter and exit mitosis but do not undergo
cytokinesis [28]. We observed that many Hela cells treated
with ZM447439 contained multiple and abnormally
shaped nuclei consistent with the inhibition of Aurora B
kinase in our treated cells (Fig. 5A). We currently do not
have an explanation for the reduction in the percentage of
cells at higher doses (5 μM).
To determine the effect of Aurora B Kinase on the phos-
phorylation of Borealin, we pretreated WT-8 cells with 2
μM ZM447439 for 1 hour and then added nocodazole for
16 hours to block them in mitosis. ZM447439 was left in
the medium during the nocodazole treatment to ensure
that cells entered mitosis with low levels of Aurora kinase
activity. Under these conditions, Borealin migrated as a
doublet similar to the cells blocked in mitosis with noco-
dazole without adding ZM447439 (Fig. 5B). Also, pre-
treatment of WT-8 cells with a higher dose of ZM447439
(10  μM) or VE465 (100 nM), another Aurora Kinase
inhibitor [30] followed by nocodazole did not block the
mitotic mobility shift of Borealin (Fig. 5C). This suggests
that Aurora B is not required to generate the phosphor-
ylated mitotic form of Borealin.
Localization of Borealin in cells that fail to divide
Similar to TD-60 and INCENP, [31], we observed that
Borealin was able to migrate to the spindle midzone even
when myosin was inhibited and cleavage was blocked
with blebbistatin (Fig. 6A–E). Interestingly, Borealin was
found to localize to a disorganized, tubulin-containing
structure found in cells exposed to blebbistatin. This struc-
ture is likely the previously described "telophase disk", a
remnant of the spindle midzone found in cytochalasin-
treated cells [32](Fig. 6A–E). These experiments indicate
that the release of Borealin from microtubules is corre-
lated with the completion of cytokinesis; in cells that
divide normally Borealin is no longer associated with
microtubules in G1 [18]. To test if blocking cytokinesis
affects the phosphorylation of Borealin, we synchronized
cells in mitosis with nocodazole. Cells were released from
the block in the presence or absence of blebbistatin. In
both cases, Borealin was mostly dephosphorylated by 8
hours post release (Fig. 6F). These results indicate that
Borealin is dephosphorylated even when cytokinesis is
blocked, and further suggests that dephosphorylation is
not sufficient to release Borealin from microtubules after
mitotic exit.
Phosphorylation of Borealin during interphase
In an experiment aimed at finding the half-life of Borealin
protein, asynchronous WT-8 cells were treated with
cyclohexamide (CHX) for different time points and the
level of Borealin was analyzed. Interestingly, Borealin
showed a mobility shift and an abundant slower migrat-
ing form after cyclohexamide treatment for 2 hours (Fig.
7A). The short time needed for cyclohexamide to induce
the phosphorylation of Borealin suggested that the effect
was not secondary to cell cycle synchronization induced
by the drug. To confirm this, cells were blocked in S phase
with hydroxyurea and then exposed to cyclohexamide for
1 or 2 hours. Even when cell cycle progression was
blocked, cyclohexamide induced the phosphorylation of
Borealin (Fig. 7B). To confirm that the mobility shift was
due to phosphorylation, WT-8 cells blocked in S phase
using hydroxyurea were exposed to cyclohexamide for 2
hours and the extracts were then treated in vitro with phos-
phatase for 1 and 4 hours and as a control with phos-
phatase and phosphatase inhibitor. The disappearance of
the slower migrating form upon phosphatase treatment
for 4 hours indicated that the shift was due to phosphor-
ylation (Fig. 7C).
Evidence that the phosphorylation of Borealin is regulated 
by a labile serine/threonine phosphatase
The effects of cyclohexamide suggest that a kinase that
phosphorylates Borealin is present in S phase, and it is
possible that it is the same kinase that phosphorylates
Borealin during mitosis. One explanation for the effects of
cyclohexamide is that a labile phosphatase keeps Borealin
dephosphorylated during interphase. Inactivation of the
phosphatase during mitosis allows phosphorylated Bore-
alin to accumulate. To test this idea, asynchronously
growing WT-8 cells, and those blocked in S phase using
hydroxyurea were treated with different concentrations of
NaF, a broad-spectrum serine/threonine phosphatase
inhibitor for 3.5 hours. Cells treated with 5, 10 and 20
mM NaF showed an increase in the phosphorylated form
of Flag-tagged and endogenous Borealin (Fig. 8A). In con-BMC Cell Biology 2007, 8:5 http://www.biomedcentral.com/1471-2121/8/5
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Effect of Aurora kinase inhibitors on the mitotic phosphorylation of Borealin Figure 5
Effect of Aurora kinase inhibitors on the mitotic phosphorylation of Borealin. The mobility shift of Borealin was determined by 
Western blotting using a 12.6% SDS-polyacrylamide gel. Transfers were stripped and reprobed for β-actin to serve as loading 
control. (A) The response of cells to different doses of ZM447439. Hela cells were treated for 16 hours with the indicated 
doses of ZM447439 to block Aurora B kinase activity and then stained to detect DNA using immunofluorescence. The per-
centage of normal, abnormal and multinucleated cells was determined using fluorescence microscopy. (B) Effect of ZM447439 
pre-treatment on mitotic phosphorylation of Borealin. WT-8 cells were treated with ZM447439 for 1 hour and then blocked 
in mitosis by treating for 16 hours with nocodazole (ZM447439 was left on during the nocodazole treatment). DMSO was 
used as a vehicle control. (C) Effect of high dose of ZM447439 and VE465 on mitotic phosphorylation of Borealin. WT-8 cells 
treated with 10 μM ZM447439 or 100 nM VE465 for 1 hour were either left to grow asynchronously or blocked in mitosis by 
treating for 16 hours with nocodazole (aurora kinase inhibitors were left on for the duration of the experiment). DMSO was 
included as a vehicle control.
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Localization and kinetics of dephosphorylation of Borealin in cells that fail to divide Figure 6
Localization and kinetics of dephosphorylation of Borealin in cells that fail to divide. HEK293 cells stably expressing Borealin-
GFP were exposed to blebbistatin (41 μM). The localization of Borealin and α-tubulin were analyzed by confocal microscopy. 
(A) Untreated, (B and C) Blebbistatin for 3.8 hrs (D and E) Blebbistatin for 45 min. (F) Borealin dephosphorylation and scheme 
of the experiment. WT-8 cells were synchronized in mitosis with nocodazole and then released from the block in the presence 
or absence of blebbistatin. Lysates were collected at the times indicated and analyzed by Western blotting. Western transfers 
were stripped and reprobed for β-actin as a loading control.
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Phosphorylation of Borealin during interphase Figure 7
Phosphorylation of Borealin during interphase. Mobility shift of Borealin was analyzed by Western blotting using a 12.6% SDS-
PAGE. Western transfers were stripped and reprobed for β-actin as a loading control. UT : Untransfected. (A) Effect of 
cyclohexamide (CHX) on asynchronous cells. Asynchronously growing WT-8 cells were treated with CHX for the indicated 
times. (B) Effect of CHX on cells blocked in S phase. WT-8 cells blocked in S phase by treating with hydroxyurea for 16 hours 
were exposed to CHX or water (vehicle) for 2 hours (in the continuous presence of hydroxyurea). (C) WT-8 cells were 
either allowed to grow asynchronously or blocked in S phase using hydroxyurea for 16 hours and then treated with CHX for 
2 hours. Cell lysates were treated with phosphatase for 1 hr (PP1) and 4 hrs (PP4) in vitro and also with phosphatase inhibitor 
(PP+Inh).
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trast to NaF, neither okadaic acid nor cyclosporine A had
any effect on the migration of Borealin suggesting that
Borealin is not dephosphorylated by PP1, PP2A, PP4, PP5
(inhibited by okadaic acid) or PP2B (inhibited by
cyclosporine A)(Fig. 8B). Our working hypothesis is that
Borealin is constantly phosphorylated during interphase,
but is rapidly dephosphorylated by a labile phosphatase.
Phosphorylated Borealin interacts with INCENP during 
mitosis
During mitosis, Borealin associates with INCENP-con-
taining complexes[18,20]. To determine which form of
Borealin binds to INCENP, immunoprecipitations per-
formed on asynchronous and mitotic WT-8 lysates using
anti-INCENP antibodies were analyzed by Western blot-
ting using an antibody to the Flag-tagged Borealin (Fig. 9).
Anti-p53 antibody was used as a negative control for
immunoprecipitation. In mitotic cells, INCENP-contain-
ing complexes almost exclusively contained the phospho-
rylated form of Borealin (Fig. 9). This was not surprising
since most of the Borealin in mitotic cells is phosphor-
ylated. However, even though the asynchronous 'input'
lysate contained more of the faster migrating, dephospho-
rylated form of Borealin, INCENP immunoprecipitates
appear to contain equal amounts of both forms of Borea-
lin (Fig. 9). These results indicate that phosphorylation
may enhance the interaction of Borealin with the CPC.
Discussion
The chromosomal passenger complex consisting of
INCENP, Survivin, Borealin and Aurora B plays important
roles in chromosome segregation at mitosis and cell divi-
sion once mitosis is complete [1]. The complex shows a
dynamic pattern of localization, being found at centro-
meres during metaphase and being deposited at the spin-
dle midzone during anaphase after sister chromatid
separation. There is evidence that targeting to the centro-
mere is in part mediated by Borealin which can bind to
DNA [20]. Targeting to the microtubules at the spindle
midzone may be mediated by INCENP which has affinity
for tubulin [23]. How the localization of the complex is
regulated is not completely understood, although the
kinesin MKlp-2 is required for re-localization of INCENP
and Aurora B from centromeres to the spindle midzone
[33]. borealin mRNA is cell cycle regulated with maximal
expression during G2 and mitosis [18,34]. Also, endog-
enous Borealin protein levels are increased in cells
blocked in mitosis using nocodazole [18,34]. We also
observed that ectopic Flag-tagged Borealin driven by a
constitute CMV promoter was more abundant in nocoda-
zole-blocked cells (Jacob and Taylor, unpublished obser-
vations). Since similar levels of GFP protein are expressed
under the control of the CMV promoter in asynchronous
and mitotic cells, we predict that the level of Borealin pro-
tein in mitosis is under post-transcriptional control. Ser-
ine 165 can be phosphorylated in vitro by Aurora B Kinase
[18], and threonine 106 conforms to a single consensus
CDK1 site (S/TP-X-K/R) in Borealin. Mutation of either
site did not disrupt the upregulation of ectopic Borealin in
mitosis (Fig. 1A and unpublished data), or alter the ability
of the Flag-tagged protein to localize to centromeres and
the spindle midzone (Fig. 2 and unpublished data). Inter-
estingly, extensive electrophoresis allowed us to detect a
phosphorylated form of Borealin that is most abundant
during mitosis. This slower migrating, phosphorylated
form of Borealin was evident for endogenous Borealin
and for exogenous, Flag-tagged Borealin in mitotic cells.
In addition, this mitotic form of Borealin was observed
when serine 165 or threonine 106 were mutated to
alanine (Fig. 1A and unpublished data), and also when
Aurora B kinase was inhibited by exposing cells to
ZM447439 or VE465. Therefore, Borealin is phosphor-
ylated during mitosis in vivo by an unknown kinase, at a
site or sites other than or in addition to S165 or T106. It is
possible that phosphorylation at T106 or S165 occurs in
vivo but does not lead to a mobility shift and our results
do not exclude this possibility.
We observed that Borealin is dephosphorylated as cells
exit mitosis. Interestingly, treating asynchronous or S
phase cells with cyclohexamide induced a mobility shift
of Borealin as a result of phosphorylation. Our model to
explain the effects of cyclohexamide is that the Borealin
kinase is active throughout the cell cycle, but is counter-
acted by a labile phosphatase that is active during inter-
phase. Inactivation of the phosphatase during mitosis
would allow accumulation of the mitotic form of Borea-
lin. Consistent with this hypothesis, we observed an
increase in the slower migrating, phosphorylated form of
Borealin when asynchronous or S phase cells were
exposed to NaF, a broad-spectrum phosphatase inhibitor.
The shifted form of Borealin induced by cyclohexamide or
NaF shows a similar mobility as the form that accumu-
lates during mitosis. Our working hypothesis is that the
same phosphorylation events are responsible for these
shifted forms. The fact that neither okadaic acid nor
cyclosporine A induced the phosphorylation of Borealin
during interphase indicates that dephosphorylation is not
accomplished by the phosphatases PP1, PP2A, PP2B, PP4
or PP5. There are other more complicated models to
explain the effects of cyclohexamide and NaF on Borealin
phosphorylation and further study will be required to
understand the molecular basis of its cell cycle-dependent
phosphorylation.
The mechanisms that control the function of Borealin and
the chromosomal passenger complex are not completely
understood. For example, as found for INCENP and
Aurora B [31] we found that the movement of Borealin
from centromeres to the spindle midzone was independ-BMC Cell Biology 2007, 8:5 http://www.biomedcentral.com/1471-2121/8/5
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ent of a functional actomyosin ring. Borealin was found at
the telophase disk, a remnant of the spindle midzone that
persists hours after cleavage has been aborted [32]. In
some cells we could observe decondensed chromatin
indicating that the binucleated daughter nuclei had
entered G1, with Borealin still attached to the remnants of
the spindle midzone (for example see Fig. 6C). The mech-
anism responsible for this persistent accumulation is not
clear. The release of Borealin from the spindle midzone
may require additional mechanisms apart from dephos-
phorylation of Borealin. One possibility is that cell divi-
sion provides a trigger to remove Borealin (and likely the
entire CPC) from the midzone microtubules.
To begin to analyze the functional significance of Borealin
phosphorylation, we studied its interaction with another
CPC protein, INCENP. Abundant, phosphorylated Borea-
lin was detected in INCENP immunoprecipitates from
mitotic cells showing that INCENP interacts with phos-
phorylated Borealin, the form that predominates during
mitosis. Analysis of INCENP immunoprecipitates from
asynchronous cells was more informative. Although Bore-
alin was mostly in the dephosphorylated form in the total
lysate, INCENP immunoprecipitated equal amounts of
both migrating forms of Borealin. This shows that the
interphase, fast migrating form of Borealin can form a
complex with INCENP, however, preference is given to
the phosphorylated form. One interpretation is that the
phosphorylation of Borealin during mitosis stabilizes its
association with the CPC. This may occur by stabilizing its
interaction with Survivin, INCENP, itself, DNA or via a
combination of those interactions. Further analysis of the
Effect of phosphatase inhibitors on Borealin Figure 8
Effect of phosphatase inhibitors on Borealin. The mobility shift of Borealin was determined by Western blotting using 12.6% 
SDS-polyacrylamide gel. Transfers were stripped and reprobed for β-actin as a loading control. (A) Effect of NaF on the migra-
tion of exogenous and endogenous Borealin. WT-8 cells blocked in S phase using hydroxyurea were either left untreated or 
treated with the indicated doses of NaF for 3.5 hours. (B) Effect of okadaic acid and cyclosporine A on Borealin. Asynchro-
nously growing WT-8 cells were treated with either okadaic acid or cyclosporine A or both for 2 hours. As a control for the 
shift, cells were treated with CHX for 2 hours.
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modification of Borealin should help to illuminate how
the CPC is assembled.
Conclusion
Our results indicate that a phosphorylated form of Borea-
lin exists in mitotic cells. Generation of this mitotic phos-
phorylated form of Borealin does not require Aurora B
Kinase activity or the residues S165 or T106 of Borealin.
Both the interphase form and the mitotic form of Borealin
can form a complex with INCENP, however there is a pref-
erence for the mitotic form. A phosphorylated form of
Borealin can also be induced in interphase cells by treat-
ment with either cyclohexamide or NaF. Borealin travels
to the spindle midzone when actin/myosin-mediated
contraction of the cleavage furrow is inhibited, and
remains attached to the remnants of the spindle in cells
that fail to divide. Borealin is dephosphorylated when
cells exit mitosis whether or not they are able to form a
functional cleavage furrow.
Methods
Cell culture and drug treatment
Cells were maintained in Dulbecco's minimal essential
medium (Gibco) with 10% fetal bovine serum and peni-
cillin/streptomycin and in a humidified atmosphere of
10% CO2 at 37°C. Chemicals were obtained from Sigma-
Aldrich unless otherwise noted. Nocodazole was used at a
concentration of 200 ng/ml, LLnL at 50 μM, blebbistatin
at 100 μM, hydroxyurea at 2 mM, Cyclohexamide at 25
μg/ml, okadaic acid at 50 nM and cyclosporine A at 100
Association of Borealin with endogenous INCENP Figure 9
Association of Borealin with endogenous INCENP. Asynchronously growing and mitotic WT-8 lysates were incubated with 
antibodies to endogenous INCENP or p53 (negative control) for immunoprecipitation and subsequently analyzed by Western 
blotting (WB) using an antibody to the Flag-tag. Transfers were stripped and probed for INCENP and β-actin as loading con-
trol. I: Interphase, M: Mitotic. Shift controls are Hela cells, asynchronously growing or blocked in mitosis with nocodazole and 
lysed with RIPA buffer. These were included as an internal conformation for the mobility shift and whether electrophoresis 
was sufficient.
UT      I       M       I        M     
p
5
3
I
N
C
E
N
P
I
N
C
E
N
P
Input IP
- - +        - +          +       - +     NOC
Flag-Borealin
Flag-Borealin 
–long exposure
INCENP
β-actin 
W
B
shift
controlsBMC Cell Biology 2007, 8:5 http://www.biomedcentral.com/1471-2121/8/5
Page 14 of 17
(page number not for citation purposes)
nM. In experiments where nocodazole was used to syn-
chronize cells, a lower concentration (60 ng/ml for 16
hours) was used to aid in its removal by multiple washes
with phosphate buffered saline (PBS). In order to collect
mitotic cells in the absence of nocodazole, WT-8 cells sta-
bly expressing ectopic Flag-Borealin were plated 1 day
before collection. Mitotic cells were collected by vigorous
agitation of the plate. Aurora B Kinase inhibitors
ZM447439 and VE465 were obtained from Astra Zeneca
and Vertex Pharmaceuticals Ltd., respectively.
Construction of T106A and S165A mutants of Borealin
A cDNA encoding Flag-tagged human Borealin protein
was previously created in our lab. This cDNA was sub-
jected to polymerase chain reaction (PCR)-mediated site-
directed mutagenesis to create T106A and S165A mutants.
For the T106A mutant, the following sets of primers were
used. To amplify the first 335-bp fragment, the forward
primer (5' AGCAGGCTCCGCGGCCGC 3') and the
reverse primer R1 containing the mutation (5' AGATT-
TCAGGGGAGCCTGAATAG 3') were used. To amplify the
second 557-bp fragment, the forward primer F2 contain-
ing the mutation (5' CTATTCAGGCTCCCCTGAAATC 3')
and the reverse primer R2 (5' TGGGTCG-
GCGCGCCCACC 3') were used. In the third PCR reaction,
the PCR products of the first two reactions were used as
templates with F1 and R2 primers to construct the final
892-bp mutated PCR product. The 892-bp fragment
between the unique Not1 and Asc1 sites in the wild type
cDNA was then replaced by the corresponding PCR prod-
uct containing the mutation to make the T106A construct.
In the S165A mutant, both S164 and S165 were mutated
to alanine. The F1 and R2 primers used for the construc-
tion for T106A construct were used for the S165A con-
struct but the following R1 and F2 primers containing the
mutation were used: R1 (5' TAGCACGAGCAGCCCTTT-
TCC 3') and F2 (5' GGAAAAGGGCTGCTCGTGCTA 3').
Competent E. coli were then transformed with the liga-
tion products. After selection on ampicillin plates, plas-
mids encoding T106A and S165A mutated versions of
borealin were purified from bacteria and used for transfec-
tion. All mutations were confirmed by DNA sequencing.
Transfections and selection of stable cell lines
For transient transfections, Hela were transfected using
either Lipofectamine 2000 (Invitrogen) or Fugene 6
(Roche). For stable cell lines, Hela cells were transfected
with a construct encoding Flag-tagged wild type Borealin
using Lipofectamine 2000. Selection was initiated by add-
ing 400 μg/ml G418, 48 hours after transfection. Stably
transfected cells were obtained two weeks after transfec-
tion.
Western blotting
Cells were lysed in buffer containing 50 mM Tris (pH 8.0),
150 mM NaCl, 1.0% NP-40, 1 mM phenyl methane sulfo-
nyl fluoride (PMSF), 1 mM dithiothreitol (DTT), protease
inhibitors (1 μg/ml aprotinin, 2 μg/ml leupeptin, 1 μg/ml
pepstatin) and phosphatase inhibitors (1 mM sodium flu-
oride and 1 mM sodium vanadate) on ice and cell lysates
were resolved by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE)(12.5% acrylamide at a
ratio of 37.5:1 acrylamide: bisacrylamide). In some exper-
iments, in order to better separate phosphorylated and
unphosphorylated forms of Borealin, lysates were sepa-
rated using either 12.6% or 15% acrylamide with a ratio
of 29.2:0.8 acrylamide: bisacrylamide [35]. The proteins
were subsequently transferred to polyvinylidenefluoride
membranes (Millipore, Bedford, MA). Western blots were
blocked in PBS containing 0.05%(v/v) Tween and 5%(w/
v) non-fat dry milk and antibodies for Western blotting
were diluted in the same buffer. Antibodies to Flag-tag
were directly conjugated to HRP (Bethyl laboratories) and
were used at a dilution of 1:2000. Antibodies to β-actin
(NeoMarkers) were diluted to 1:5000, antibodies to GFP
(Santa Cruz Biotechnologies) were diluted to 1:500 and
antibodies to Cyclin B1 (NeoMarkers) were diluted to
1:300. Rabbit anti-Borealin antibody was used at a dilu-
tion of 1:10,000 and anti-INCENP (Upstate) antibody
was used at a concentration of 0.5 μg/ml. Goat anti-
mouse and goat anti-rabbit secondary antibodies conju-
gated to HRP (Santa Cruz Biotechnologies) were diluted
to 1:2000 and 1:3000, respectively and detected by
enhanced chemiluminescence (Dupont, Wilmington,
DE)(Clifford, Beljin, Stark & Taylor, 2003).
Phosphatase treatment
Hela cells transiently transfected with wild-type or T106A
Flag-Borealin were left untreated or treated with nocoda-
zole for 14 hrs. Cells were lysed with RIPA buffer (10 mM
TRIS pH 7.4, 150 mM NaCl, 1% NP-40, 1% sodium deox-
ycholate, 0.1% SDS) containing aprotinin, leupeptin,
pepstatin A, PMSF and DTT as described above, however
sodium fluoride and sodium vanadate were omitted. Cell
lysates were left untreated or treated with 1.5 units of calf
intestinal phosphatase (Promega) in the reaction buffer
provided for 1 or 4 hrs at 37°C. For samples where the
added phosphatase was inhibited with phosphatase
inhibitors, we also added NaF and NaVO3, both at a con-
centration of 1 mM. Reactions were stopped by adding a
Laemlli loading buffer stock to attain the following final
buffer composition (2% [w/v] SDS, 50 mM Tris, pH 6.8,
10% [v/v] glycerol and 100 mM DTT).
Co-Immunoprecipitation
Asynchronously growing or mitotic WT-8 cells (blocked
in mitosis using 60 ng/ml nocodazole for 16 hours) were
lysed as previously described with some modificationsBMC Cell Biology 2007, 8:5 http://www.biomedcentral.com/1471-2121/8/5
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[18]. Cells were incubated in lysis buffer containing 50
mM Tris-HCl (pH 8.0), 400 mM NaCl, 0.5% NP-40, 0.1%
deoxycholate, 1 mM PMSF, 1 μg/ml protease inhibitors
(aprotinin, leupeptin and pepstatin), 1 mM phosphatase
inhibitors (sodium fluoride and sodium vanadate), 30
μg/ml RNase A and 80 U/ml DNase1 for 20 minutes on
ice. 4 μg/ml anti-INCENP antibodies and 4 μg/ml anti-
p53 antibodies (negative control)(Santa Cruz Biotechnol-
ogy) coupled to protein-G magnetic beads were added to
the cleared lysate and rocked for 5 hours at 4°C. The beads
were washed twice with the lysis buffer (without RNase A
and DNase1) and once with wash buffer containing 10
mM Tris-HCl (pH 7.4) and 150 mM NaCl. The washed
beads were analyzed by SDS-polyacylamide gel electro-
phoresis and subsequent Western blotting.
Immunofluorescence and confocal microscopy
For immunofluorescence microscopy, Hela cells grown
on coverslips were transiently transfected with constructs
encoding Flag-tagged wild type, T106A and S165A
mutated versions of borealin. 48 hours after transfection,
cells were fixed with 100% methanol followed by 100%
acetone and blocked with PBS containing 0.1% bovine
serum albumin (BSA) overnight at 4°C. Blocked cells
were incubated with rabbit anti-Flag (Sigma) and mouse
anti-α tubulin (Sigma) primary antibodies for one hour at
room temperature. Cells were then incubated with Alex-
afluor conjugated goat anti-rabbit (Molecular Probes) and
fluorescein isothiocyanate-conjugated goat anti-mouse
(Sigma) secondary antibodies for 45 minutes at room
temperature. Nuclei were stained with 4', 6-Diamidino-2-
phenylindole and coverslips were mounted using
Vectashield (Vector Laboratories). Standard fluorescent
images were captured using a spot camera connected to an
Axiophot fluorescence microscope. To obtain confocal
images, HEK293 cells stably expressing Borealin-GFP were
fixed with 2% formaldehyde in PBS. Cells were permeabi-
lized with 150 mM NaCl, 10 mM Tris (pH 7.7), 0.1% Tri-
ton-X-100 (v/v), and 0.1% BSA (w/v). Microtubules were
detected with a monoclonal antibody to α-tubulin fol-
lowed by goat-anti-mouse Alexafluor 568 (Molecular
Probes). Borealin was detected by GFP fluorescence and
confocal images were captured with an inverted 1 × 70
confocal microscope with Fluoview software (Olympus-
Fluoview).
Production of rabbit anti-Borealin antiserum
To raise polyclonal antisera, a fusion containing glutath-
ione-S-transferase (GST) followed by Borealin at the car-
boxyl-terminus was created. Full length borealin  was
amplified by PCR using a forward primer containing a
Bcl1 site (5-GCGGTGATCACTCCTAGGAAGGGCAG-
TAGTC-3') and a reverse primer with an EcoR1 site (5'-
GAATTCTCATTTGTGGGTCCGTATGCTGCT-3'). The PCR
product was digested and ligated into pGEX-3X digested
with BamH1 and EcoR1, clones were tested by restriction
mapping and confirmed by DNA sequencing. The gst-bore-
alin was transformed into Rosetta strain of E. coli (Nova-
gen), which was grown at 37C for 16 h and induced with
IPTG for 3 h. Under these conditions, GST-Borealin enters
inclusion bodies. To isolate the inclusion bodies, bacterial
pellets were resuspended in PBS containing aprotinin,
leupeptin, pepstatin A, PMSF and 0.1% lysozyme (w/v).
Bacteria were disrupted by sonication and insoluble mate-
rial collected by centrifugation. The pellet was resus-
pended in wash buffer (50 mM Tris pH 8.0, 2% (v/v)
Triton-X-100, 10 mM EDTA) containing 0.5 M Urea, and
insoluble material collected by centrifugation. The pellet
was resuspended in wash buffer containing 1 M Urea, and
again subject to centrifugation. The pellet was resus-
pended in wash buffer with 2 M Urea, and insoluble mate-
rial collected by centrifugation. The pellet, representing
washed inclusion bodies was resuspended in PBS and sent
to Proteintech Group Inc. for solubilization, injection
into rabbits and production of custom antiserum.
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